Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in HIV Seropositivity: HELP
Sara Lodi
Based on 10 articles published since 2008
||||
Expertise Level
The expertise of Sara Lodi ranks in the
  • Top 0.28%
  • ... of 22,224 published authors worldwide on HIV Seropositivity
  • ... from 2008 through 2018
  • ... based on contributions to 10 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Medical Research Council      
2013
  • Medical Research Council, University College London, London, United Kingdom ; Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24086588
  • Clinical Trials Unit, Medical Research Council, London, UK. · Pubmed 23117980
2011
  • MRC Clinical Trials Unit, University College London, UK. · Pubmed 21921225
2010
  • MRC Clinical Trials Unit, London, UK. · Pubmed 20885283
  • Medical Research Council, Clinical Trials Unit, 222 Euston Rd, London NW1 2DA, UK. · Pubmed 20442214
Probable:    Instituto de Salud Carlos III      
2013
  • Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24244330
  • Medical Research Council, University College London, London, United Kingdom ; Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24086588
  • Clinical Trials Unit, Medical Research Council, London, UK. · Pubmed 23117980
2012
  • Instituto de Salud Carlos III, Centro Nacional de Epidemiologia, Madrid, Spain. · Pubmed 22826124
Probable:    University College London      
2013
  • Medical Research Council, University College London, London, United Kingdom ; Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24086588
2011
  • MRC Clinical Trials Unit, University College London, UK. · Pubmed 21921225
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Sara Lodi in 2008-2018 about HIV Seropositivity:

  • Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection. 2013
  • Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure. 2013
  • Risk of tuberculosis following HIV seroconversion in high-income countries. 2013
  • Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion--reply. 2013
  • Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion. 2012
  • The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study. 2012
  • Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. 2012
  • Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines. 2011
  • CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era. 2010
  • Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. 2010
Show List of Full Article Records
Google Searches

Learn more about Sara Lodi using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Medical Research Council
Instituto de Salud Carlos III
University College London
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Medical Research Council
2013
  • Medical Research Council, University College London, London, United Kingdom ; Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24086588
  • Clinical Trials Unit, Medical Research Council, London, UK. · Pubmed 23117980
2011
  • MRC Clinical Trials Unit, University College London, UK. · Pubmed 21921225
2010
  • MRC Clinical Trials Unit, London, UK. · Pubmed 20885283
  • Medical Research Council, Clinical Trials Unit, 222 Euston Rd, London NW1 2DA, UK. · Pubmed 20442214
Instituto de Salud Carlos III
2013
  • Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24244330
  • Medical Research Council, University College London, London, United Kingdom ; Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24086588
  • Clinical Trials Unit, Medical Research Council, London, UK. · Pubmed 23117980
2012
  • Instituto de Salud Carlos III, Centro Nacional de Epidemiologia, Madrid, Spain. · Pubmed 22826124
University College London
2013
  • Medical Research Council, University College London, London, United Kingdom ; Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24086588
2011
  • MRC Clinical Trials Unit, University College London, UK. · Pubmed 21921225
Yearly article counts 00000431200
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.